Abbott paid $1.24 billion for the remaining 83.1 percent of AMO’s stock. As a final step of the acquisition, Abbott will form a short-form merger as soon as is practical. The remaining AMO stockholders will receive $22 per share as a result of the merger.
Read the Abbott news release regarding the AMO acquisition.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
